Quest PharmaTech (TSXV:QPT) Interest Expense : C$-0.02 Mil (TTM As of Oct. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Quest PharmaTech's interest expense for the three months ended in Oct. 2023 was C$ -0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Oct. 2023 was C$-0.02 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Quest PharmaTech's Operating Income for the three months ended in Oct. 2023 was C$ -0.16 Mil. Quest PharmaTech's Interest Expense for the three months ended in Oct. 2023 was C$ -0.01 Mil. Quest PharmaTech did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Quest PharmaTech Interest Expense Historical Data

The historical data trend for Quest PharmaTech's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest PharmaTech Interest Expense Chart

Quest PharmaTech Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Interest Expense

Get a 7-Day Free Trial

-0.01

-0.02

Quest PharmaTech Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Interest Expense	Get a 7-Day Free Trial															-0.01	-0.01	-	-0.01	-0.01

Quest PharmaTech Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.02 Mil.

Quest PharmaTech (TSXV:QPT) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Quest PharmaTech's Interest Expense for the three months ended in Oct. 2023 was C$-0.01 Mil. Its Operating Income for the three months ended in Oct. 2023 was C$-0.16 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Oct. 2023 was C$0.00 Mil.

Quest PharmaTech's Interest Coverage for the quarter that ended in Oct. 2023 is calculated as

Quest PharmaTech did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Quest PharmaTech (TSXV:QPT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4

Website

http://www.questpharmatech.com

Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.

Executives

Ragupathy Madiyalakan

Director

Quest PharmaTech (TSXV:QPT) Headlines

No Headlines